ArticleOncoTargets and therapy2018

Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study.

Yizhuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.